Pharma firm Inotiv discloses data breach after ransomware attack
Source Reddit InfoSec News
Description
Pharmaceutical company Inotiv has disclosed a data breach following a ransomware attack that compromised its systems. The attack involved malware that encrypted or otherwise disrupted access to critical data, leading to unauthorized data exposure. Although specific technical details and exploited vulnerabilities are not provided, the incident highlights the ongoing threat ransomware poses to sensitive sectors such as pharmaceuticals. The breach could impact confidentiality of proprietary research, patient data, and operational integrity. European organizations in the pharmaceutical and biotech sectors should be vigilant, as similar attacks could target them due to the high value of their data. Mitigation requires tailored ransomware defenses including network segmentation, robust backup strategies, and incident response readiness. Countries with significant pharmaceutical industries and research hubs, such as Germany, Switzerland, and the UK, are particularly at risk. Given the high impact on confidentiality and availability, ease of exploitation typical of ransomware, and no requirement for user interaction once inside, the severity is assessed as high. Defenders must prioritize detection, prevention, and rapid response to ransomware threats to protect critical healthcare and research infrastructure.